CD8A and COVID-19: In contrast, SARS-CoV-2 specific CD4+ and CD8+ T cell responses are associated with reduced disease severity (Moderbacher et al., 2020) and the appearance of SARS-CoV-2-specific T cell responses is delayed and reduced in severe COVID-19 cases (Tan et al., 2021).